MIH en es it fr

MIH Brand names, MIH Analogs

MIH Brand Names Mixture

  • No information avaliable

MIH Chemical_Formula

C12H19N3O

MIH RX_link

http://www.rxlist.com/cgi/generic3/procarb.htm

MIH fda sheet

http://www.accessdata.fda.gov/scripts/cder/onctools/summary.cfm?ID=44

MIH msds (material safety sheet)

MIH MSDS

MIH Synthesis Reference

No information avaliable

MIH Molecular Weight

221.299 g/mol

MIH Melting Point

223 oC

MIH H2O Solubility

1420 mg/L

MIH State

Solid

MIH LogP

1.234

MIH Dosage Forms

Capsule

MIH Indication

For use with other anticancer drugs for the treatment of stage III and stage IV Hodgkin's disease.

MIH Pharmacology

Procarbazine is an antineoplastic in the class of alkylating agents and is used to treat various forms of cancer. Alkylating agents are so named because of their ability to add alkyl groups to many electronegative groups under conditions present in cells. They stop tumor growth by cross-linking guanine bases in DNA double-helix strands - directly attacking DNA. This makes the strands unable to uncoil and separate. As this is necessary in DNA replication, the cells can no longer divide. In addition, these drugs add methyl or other alkyl groups onto molecules where they do not belong which in turn inhibits their correct utilization by base pairing and causes a miscoding of DNA. Procarbazine is cell-phase specific for the S phase of cell division.

MIH Absorption

Procarbazine is rapidly and completely absorbed.

MIH side effects and Toxicity

LD50=785 mg/kg (orally in rats)

MIH Patient Information

MIH Organisms Affected

Humans and other mammals